Literature DB >> 31600780

Functional assessment of variants associated with Wolfram syndrome.

Melissa Riachi1, Sebahat Yilmaz2, Erdal Kurnaz2, Zehra Aycan2, Semra Çetinkaya2, Lisbeth Tranebjærg3,4, Nanna Dahl Rendtorff3, Maria Bitner-Glindzicz1, Detlef Bockenhauer5,6, Khalid Hussain1,7.   

Abstract

Wolfram syndrome (WS) is a heterogeneous multisystem neurodegenerative disorder with two allelic variations in addition to a separate subtype known as WS type 2. The wide phenotypic spectrum of WS includes diabetes mellitus and optic atrophy which is often accompanied by diabetes insipidus, deafness, urological and neurological complications in combination or in isolation. To date, the understanding of the genotype-phenotype relationship in this complex syndrome remains poorly understood. In this study, we identified and explored the functionality of rare and novel variants in the two causative WS genes WFS1 and CISD2 by assessing the effects of the mutations on the encoded proteins Wolframin and ERIS, in a cohort of 12 patients with autosomal recessive WS, dominant WS and WS type 2. The identified pathogenic variants included missense changes, frameshift deletions and insertions in WFS1 and an exonic deletion in CISD2 which all altered the respective encoded protein in a manner that did not correlate to the phenome previously described. These observations suggest the lack of genotype-phenotype correlation in this complex syndrome and the need to explore other molecular genetic mechanisms. Additionally, our findings highlight the importance of functionally assessing variants for their pathogenicity to tackle the problem of increasing variants of unknown significance in the public genetic databases.
© The Author(s) 2019. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31600780     DOI: 10.1093/hmg/ddz212

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  2 in total

Review 1.  Clinical Spectrum Associated with Wolfram Syndrome Type 1 and Type 2: A Review on Genotype-Phenotype Correlations.

Authors:  Maurizio Delvecchio; Matteo Iacoviello; Antonino Pantaleo; Nicoletta Resta
Journal:  Int J Environ Res Public Health       Date:  2021-04-30       Impact factor: 3.390

Review 2.  Wolfram Syndrome Type 2: A Systematic Review of a Not Easily Identifiable Clinical Spectrum.

Authors:  Francesco Maria Rosanio; Francesca Di Candia; Luisa Occhiati; Ludovica Fedi; Francesco Paolo Malvone; Davide Fortunato Foschini; Adriana Franzese; Enza Mozzillo
Journal:  Int J Environ Res Public Health       Date:  2022-01-12       Impact factor: 3.390

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.